The goal of QR-02 is to treat and reduce dysplasia levels, potentially offering a curative solution for oral leukoplakia, an outcome that would mark a significant breakthrough in oral medicine. By ...

can lead to premalignant conditions in the oral cavity like Oral Sub Mucus Fibrosis, Leukoplakia and erythroplakia which can ...